Penn Medicine Provider
Infectious Diseases
Erica J. Weinstein, MD, MSCE
Accepting new patients
Sees patients age 18 and up
Penn Infectious Diseases Penn Presbyterian

About me

  • Assistant Professor of Clinical Medicine (Infectious Diseases)

Education and training

  • Medical School: Albert Einstein College of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Weinstein is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Weinstein EJ, Stephens-Shields A, Newcomb C, Silibovsky R, Nelson C, O'Donnell JA, Glaser LJ, Hsieh E, Hanberg JS, Akgun KM, Tate JP, King Jr. JT, Lo Re III V Determinants of Prosthetic Joint Infection According to Time Following Total Knee Arthroplasty: A Retrospective Cohort Study Among US Veterans , ID Week : 2023


Weinstein EJ, Stephens-Shields A, Newcomb C, Silibovsky R, Nelson C, O'Donnell JA, Glaser LJ, Hsieh E, Hanberg JS, Akgun KM, Tate JP, King Jr. JT, Lo Re III V Incidence and Microbiology of Prosthetic Joint Infection According to Time Following Total Knee Arthroplasty: A Retrospective Cohort Study Among US Veterans , ID Week: 2023


Weinstein EJ, Stephens-Shields AJ, Newcomb CW, Silibovsky R, Nelson CL, O'Donnell JA, Glaser LJ, Hsieh E, Hanberg JS, Tate JP, Akgün KM, King JT Jr, Lo Re V 3rd. Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee Arthroplasty , JAMA Netw Open, 6(10): 2023,e2340457


Weinstein EJ, Ritchey ME, Lo Re V 3rd. Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real-world healthcare databases , Pharmacoepidemiol Drug Saf, 32(2): 2023,1-8


Spellberg B, Aggrey G, Brennan MB, Footer B, Forrest G, Hamilton F, Minejima E, Moore J, Ahn J, Angarone M, Centor RM, Cherabuddi K, Curran J, Davar K, Davis J, Dong MQ, Ghanem B, Hutcheon D, Jent P, Kang M, Lee R, McDonald EG, Morris AM, Reece R, Schwartz IS, So M, Tong S, Tucker C, Wald-Dickler N, Weinstein EJ, Williams R 2nd, Yen C, Zhou S, Lee TC; WikiGuidelines Group. Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement , JAMA Netw Open, 5(5): 2022,e2211321


Hanberg JS, Hsieh E, Akgün KM, Weinstein E, Fraenkel L, Justice AC; VACS Project Team. Incident Rheumatoid Arthritis in HIV Infection: Epidemiology and Treatment , Arthritis Rheumatol, 73(12): 2021,2189-2199


Weinstein EJ, Stephens-Shields A, Loabile B, Yuh T, Silibovsky R, O’Donnell J, Nelson C, Hsieh E, Hanberg J, Akgun K, Tate J, Lo Re V 3rd Development and Validation of Case-Finding Algorithms to Identify Prosthetic Joint Infections After Total Knee Arthroplasty , 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual: 2021


Weinstein EJ, Stephens-Shields A, Loabile B, Yuh T, Silibovsky R, Nelson CL, O'Donnell JA, Hsieh E, Hanberg JS, Akgün KM, Tate JP, Lo Re V 3rd. Development and validation of case-finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data , Pharmacoepidemiol Drug Saf, 30(9): 2021,1184-1191


Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments , J Am Acad Dermatol, 84(5): 2021,1254-1268


Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 , J Am Acad Dermatol, 83(6): 2020,1704-1716